Has Ron Avraham, MD received payments from drug or device companies?

Yes. Drug and device makers reported $435 in general payments to Ron Avraham, MD across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ron Avraham, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ron Avraham, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ron Avraham, MD

Physical Medicine & Rehabilitation · Plymouth, MANPI 1588934251

Payments from drug & device makers

$435in general payments, 2019–2025

Across 11 payments — averaging $39.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$151
Stryker$94
Johnson & Johnson$87
Nevro Corp.$38
Bioventus LLC$26
Boston Scientific$22
plus $17 from 1 others

What the payments were for

Food & beverage$435100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	2	$151
Stryker	1	$94
Johnson & Johnson	2	$87
Nevro Corp.	2	$38
Bioventus LLC	2	$26
Boston Scientific	1	$22
Avanos Medical	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OCTRODE$110

How this compares

$435 in reported general payments places this provider in the 70th percentile of 244 physical medicine & rehabilitation providers in Massachusetts.

See all physical medicine & rehabilitation providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$330,828

Medicare patients

883

Services billed

3,199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	86	$1,077
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	25	$292
Pregabalin	12	$253
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	11	$100
Meloxicam	18	$98
Tramadol Hcl	13	$41

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Plymouth

Brett TeranPlymouth$1K
Zachary BohartBurlington$654K
John KeelBoston$113K
Marc van de RijnCharlestown$89K
Sabrina PaganoniCharlestown$80K
Edward PhillipsBoston$75K
Walter SussmanWellesley$50K
Stephen KoelbelWeymouth$24K
Shanti PintoBoston$22K
Moorice CaparoCharlestown$18K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →